Book contents
- Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome
- Copyright page
- Contents
- Contributors
- Chapter 1 Introduction to and History of Polycystic Ovary Syndrome
- Chapter 2 Polycystic Ovary Syndrome: From Phenotype to Genotype
- Chapter 3 The Epidemiology of Polycystic Ovary Syndrome
- Chapter 4 Ovarian Ultrasonography in Polycystic Ovary Syndrome
- Chapter 5 The Classification of Polycystic Ovary Syndrome Informed by the International Guideline 2018
- Chapter 6 The Relevance of the Anti-Müllerian Hormone in Polycystic Ovary Syndrome Diagnosis and Management
- Chapter 7 Origins of Polycystic Ovary Syndrome In Utero
- Chapter 8 Adrenal and Polycystic Ovary Syndrome
- Chapter 9 Polycystic Ovary Syndrome and Environmental Toxins
- Chapter 10 Lifestyle in Polycystic Ovary Syndrome
- Chapter 11 Ovulation Induction in Polycystic Ovary Syndrome
- Chapter 12 Ovarian Surgery for Ovulation Induction
- Chapter 13 In Vitro Fertilization and Assisted Reproductive Technologies in Polycystic Ovary Syndrome
- Chapter 14 Pregnancy Complications and Children Outcomes in Patients with Polycystic Ovarian Syndrome
- Chapter 15 The Role of In Vitro Maturation in Polycystic Ovary Syndrome
- Chapter 16 The Treatment of Obesity in Polycystic Ovary Syndrome
- Chapter 17 Mood Disorders in Polycystic Ovary Syndrome
- Chapter 18 The Long-Term Health Consequences of Polycystic Ovary Syndrome
- Chapter 19 Polycystic Ovary Syndrome
- Chapter 20 Cancer and Polycystic Ovary Syndrome
- Index
- References
Chapter 9 - Polycystic Ovary Syndrome and Environmental Toxins
Published online by Cambridge University Press: 13 May 2022
- Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome
- Copyright page
- Contents
- Contributors
- Chapter 1 Introduction to and History of Polycystic Ovary Syndrome
- Chapter 2 Polycystic Ovary Syndrome: From Phenotype to Genotype
- Chapter 3 The Epidemiology of Polycystic Ovary Syndrome
- Chapter 4 Ovarian Ultrasonography in Polycystic Ovary Syndrome
- Chapter 5 The Classification of Polycystic Ovary Syndrome Informed by the International Guideline 2018
- Chapter 6 The Relevance of the Anti-Müllerian Hormone in Polycystic Ovary Syndrome Diagnosis and Management
- Chapter 7 Origins of Polycystic Ovary Syndrome In Utero
- Chapter 8 Adrenal and Polycystic Ovary Syndrome
- Chapter 9 Polycystic Ovary Syndrome and Environmental Toxins
- Chapter 10 Lifestyle in Polycystic Ovary Syndrome
- Chapter 11 Ovulation Induction in Polycystic Ovary Syndrome
- Chapter 12 Ovarian Surgery for Ovulation Induction
- Chapter 13 In Vitro Fertilization and Assisted Reproductive Technologies in Polycystic Ovary Syndrome
- Chapter 14 Pregnancy Complications and Children Outcomes in Patients with Polycystic Ovarian Syndrome
- Chapter 15 The Role of In Vitro Maturation in Polycystic Ovary Syndrome
- Chapter 16 The Treatment of Obesity in Polycystic Ovary Syndrome
- Chapter 17 Mood Disorders in Polycystic Ovary Syndrome
- Chapter 18 The Long-Term Health Consequences of Polycystic Ovary Syndrome
- Chapter 19 Polycystic Ovary Syndrome
- Chapter 20 Cancer and Polycystic Ovary Syndrome
- Index
- References
Summary
Polycystic ovary syndrome (PCOS) is now globally recognized as the most common endocrinopathy in women of reproductive age and has a prevalence of 5–21% depending on the criteria used (NIH, Rotterdam or Androgen Excess Society). What is special about the syndrome is its dual entity involving both the reproductive and the metabolic profile of the women affected. As a result, any intrinsic or extrinsic factors affecting both these components could lead to pathophysiological alterations that characterize PCOS. In fact, the heterogenicity of the syndrome suggests that, apart from the genetic background, the role of the environment and a person’s lifestyle are equally important. In particular, during the last twenty years, interest has been drawn to the impact of certain environmental toxins, referred to by the terms “endocrine disruptors” or “endocrine disruptive chemicals” (EDCs), which may modify both reproductive and metabolic pathways. Western civilization advancements in industrial products and food processing have led to increased daily exposure to plasticizers, such as bisphenol A (BPA) and phthalates, as well as dietary glycotoxins, such as advanced glycation end products (AGEs), which may exert adverse effects on reproduction and metabolism throughout the female lifespan.
Keywords
- Type
- Chapter
- Information
- Polycystic Ovary Syndrome , pp. 80 - 91Publisher: Cambridge University PressPrint publication year: 2022